Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 77.93
-1.25 (-1.58%)
At close: Mar 6, 2026
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 17.8 billion as of March 6, 2026. Its market cap has decreased by -24.91% in one year.
Market Cap
17.80B
Enterprise Value
20.35B
Revenue
14.10B
Ranking
n/a
PE Ratio
17.13
Stock Price
77.93
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 17.80B, an increase of 149.19%. That is a compound annual growth rate of 21.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.80B | -7.88% |
| Dec 31, 2025 | 19.33B | 24.21% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 108.57B |
| Abbott Laboratories (Pakistan) | 89.45B |
| AGP Limited | 53.49B |
| The Searle Company | 50.92B |
| Highnoon Laboratories | 45.89B |
| Ferozsons Laboratories | 14.72B |
| Macter International | 13.50B |
| Otsuka Pakistan | 4.43B |